Last $27.18 USD
Change Today -1.16 / -4.09%
Volume 307.2K
As of 5:20 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jonathon M. Singer

Chief Financial Officer and Executive Vice President, Sagent Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

As of Fiscal Year 2013


Mr. Jonathon M. Singer has been the Chief Financial Officer at Sagent Pharmaceuticals Inc. since September 2011 and its Executive Vice President since March 2012. Mr. Singer responsible for Sagent's finance and accounting functions. He has more than 26 years of finance experience with publicly-traded companies. He served as Senior Vice President, Treasurer, Secretary and Chief Financial Officer of Landauer Inc., from October 16, 2006 to September 9, 2011 and also served ...

Read Full Background

Corporate Headquarters*

1901 North Roselle Road
Schaumburg, Illinois 60195

United States

Phone: 847-908-1600
Fax: 847-908-1601

Board Members Memberships*

There is no Board Members Memberships data available.


Northwestern University
Miami University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$330,762

Stock Options*

Restricted Stock Awards$115,002
All Other Compensation$5,625
Exercisable Options29,832
Exercisable Options Value$152,989
Unexercisable Options46,565
Unexercisable Options Value$276,332
Total Value of Options$429,320
Total Number of Options76,397

Total Compensation*

Total Annual Cash Compensation$502,155
Total Short Term Compensation$330,762
Other Long Term Compensation$120,627
Total Calculated Compensation$732,156
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SGNT:US $27.18 USD -1.16


Friedhelm Blobel Ph.D.Chief Executive Officer, President, Executive Director and Member of Business Development Committee
SciClone Pharmaceuticals, Inc.
Aijaz Tobaccowalla Managing Director, Director, Member of Nomination and Remuneration Committee and Member of Board Administrative Committee
Pfizer Limited
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals Inc.
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAGENT PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at